Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
3.140
+0.140 (4.67%)
At close: May 12, 2025, 4:00 PM
3.120
-0.020 (-0.64%)
After-hours: May 12, 2025, 4:34 PM EDT
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $18.49 million as of May 12, 2025. Its market cap has increased by 163.46% in one year.
Market Cap
18.49M
Enterprise Value
13.75M
1-Year Change
163.46%
Ranking
Category
Stock Price
$3.14
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $18.49M, a decrease of -82.14%. That is a compound annual growth rate of -32.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 17.67M | -30.07% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | 104.41M | 0.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |